In the previous study, we analyzed a smaller cohort of 282 invasive breast cancer cases containing mainly ERα positive and HER2 negative luminal A/B samples, with only 13 cases being HER2 positive [11]. Here, ERBB2 is linked to invasive breast carcinoma.